ČR participating in the Widening process under the European Parliament’s PerMed call: CARMEN2026

The Ministry of Health / the ČR Health Research Agencyhave joined the so-called Widening process following the first round of the transnational call for proposals under the European Partnership for Personalised Medicine(EP PerMed):Personalised Medicine for CARdiovascular, MEtabolic, and Kidney diseases (“CARMEN 2026”).

What is the Widening Process?

In the second round of the EP PerMed CARMEN 2026 call, Czech researchers have the opportunity to join a successful project consortium from the first round, provided that:

• will addvalue to the project;
• The coordinator of a successful project consortium will approve participation by means ofa Letter of Intent;
• The Ministry of Health will confirm the availability of funds for this purpose. 

Detailed information on the national eligibility criteria is available in the document“Eligibility Criteria for Czech Applicants to the Call,”which can be found on the AZV  website AZV 03-prirucka_vyzva-PerMed_2025.pdf, starting on page 26. 

Where can I find the successful project consortia from the first round of the EP PerMed_CARMEN2026 call? 

The platform is now open to interested parties B2Matchis open to interested parties, where they can connect with coordinators of successful projects seeking new partners from underrepresented countries. More information is also available on the official website of EP PerMed.